Number of Shares
723,273.00
Current Holdings Value*
$5.81 Mil
% of Portfolio
0.49%
Total Estimate Gain
$-5.21 Mil
% of Total Estimate Gain
-73.72%

GILEAD SCIENCES, INC.'s Kalaris Therapeutics Inc Holding Summary

As of 2025-03-31, GILEAD SCIENCES, INC. held 723,273.00 shares of Kalaris Therapeutics Inc(KLRS), totaling $5.81 Mil. This investment constitutes 0.49% of their stock portfolio, and GILEAD SCIENCES, INC. now holds 3.87% of the outstanding Kalaris Therapeutics Inc(KLRS) stock.

The initial trade took place in 2025Q1. And since then GILEAD SCIENCES, INC. has made 1 purchases of KLRS, at an average price of $9.78, for a total of 723,273.00 shares. Based on historical transaction data and KLRS's current price of $2.57, GILEAD SCIENCES, INC.'s estimated gain on his KLRS holdings is $-5.21 Mil, reflecting a -73.72% gain to date.

GILEAD SCIENCES, INC. KLRS ($2.57) Holding Chart

GILEAD SCIENCES, INC. KLRS ($2.57) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1